Pregnant women will soon have free access to a vaccine that protects newborns from respiratory syncytial virus (RSV), the leading cause of hospitalisation for babies.
RSV is a highly contagious virus that affects the nose, throat and lungs. Almost all infants will be infected with RSV before the age of two, and the virus is responsible for over 12,000 babies a year being admitted to hospital.
